March 4, 2020 / 10:22 PM / in a month

BRIEF-Opiant Pharmaceuticals Reports Q4 Earnings Per Share Of $0.20

March 4 (Reuters) - Opiant Pharmaceuticals Inc:

* OPIANT PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q4 EARNINGS PER SHARE $0.20

* Q4 EARNINGS PER SHARE ESTIMATE $-2.13 — REFINITIV IBES DATA

* QTRLY REVENUE $7.7 MILLION VERSUS $4.8 MILLION

* AS OF DECEMBER 31, 2019, OPIANT HAD CASH AND CASH EQUIVALENTS OF $31.9 MILLION

* EXPECT FY 2020 ROYALTY REVENUE FROM ADAPT LICENSE FOR SALE OF NARCAN NASAL SPRAY OF ABOUT $26.2 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below